SDZXF:OTCMKTS
Sandoz Group AG
US$ ८०.४०
०.००%
(०.००) 1D
सेप्टेम्बर १४, १२:१९:४८ GMT-४ · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SDZXF...
Mkt. cap
३०.१६ अरब
Avg. vol.
१२४.००
Volume
१२.००
52-wk high
US$ ९४.५५
52-wk low
US$ ५५.५०
Shares outstanding
४४.०० करोड
No. of employees
२० हजार
Mkt. cap
३०.१६ अरब
Avg. vol.
१२४.००
Volume
१२.००
52-wk high
US$ ९४.५५
52-wk low
US$ ५५.५०
Shares outstanding
४४.०० करोड
No. of employees
२० हजार
News stories
From web sources and news partners
Investing.com Nigeria
·
१ दिन पहिले
Sandoz gets Canadian approval for generic Ozempic drug By Investing.com
Profile
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkirchen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
About Sandoz Group AG